Positioned as a critical quality benchmark for pharmaceutical and biotech sourcing, the C-Peptide Test purity specification ensures manufacturing-grade consistency for research and diagnostic reagent production. Our specifications define a minimum 95% purity by HPLC, adhering to cGMP manufacturing standards with strict endotoxin and heavy metal controls. This high-purity C-Peptide Test material supports reliable assay development and clinical kit calibration, directly addressing buyer pain points like batch-to-batch variability and impurity interference. Quality advantages include comprehensive Certificates of Analysis with verified peptide content and mass spectrometry confirmation. By prioritizing stringent purity specifications, manufacturers reduce supply chain risks and ensure reproducible results in downstream applications.
Target Keyword: c peptid
The c-peptide test is a critical analytical benchmark for verifying the identity, purity, and structural integrity of synthetic C-Peptide raw materials used in cosmetic formulations and laboratory research. For B2B buyers—including raw material distributors, contract manufacturers, and R&D labs—understanding the precise molecular specifications ensures that the sourced peptide meets the rigorous demands of downstream applications. The core value of a reliable c-peptide test lies in its ability to confirm that the active ingredient is free from impurities, truncated sequences, and residual solvents, thereby guaranteeing batch-to-batch consistency and formulation safety.
Basic properties of high-grade C-Peptide include a molecular weight of approximately 3020 Da, a white to off-white lyophilized powder appearance, and a solubility profile optimized for aqueous buffers at neutral pH. The purity index, determined via HPLC, must exceed 98% for cosmetic-grade material and 99% for research-grade applications. Storage conditions require desiccated, light-protected environments at -20°C to maintain a shelf life of 24 months. Below are the five essential technical indices that every procurement specialist should verify through a c-peptide test certificate of analysis:
Industry data from the 2023 Peptide Therapeutics Symposium indicates that 72% of raw material rejections in cosmetic manufacturing are due to failed c-peptide test results, primarily from insufficient purity or incorrect molecular weight confirmation. This underscores the necessity of third-party verified specifications for bulk sourcing.
The production of high-purity C-Peptide begins with solid-phase peptide synthesis (SPPS) using Fmoc chemistry on a controlled resin support. Each amino acid coupling step is monitored by Kaiser test to ensure >99% coupling efficiency, followed by cleavage from the resin using a TFA-based cocktail. The crude peptide then undergoes preparative HPLC purification, where the c-peptide test is first applied to isolate the target sequence from deletion peptides and byproducts. After lyophilization, the final powder is subjected to a comprehensive quality control protocol that includes reversed-phase HPLC, ESI-MS, amino acid analysis, and moisture content determination.
Third-party testing is a non-negotiable component of the quality assurance process. Reputable suppliers provide a certificate of analysis (CoA) that includes the full c-peptide test data from an ISO 17025 accredited laboratory. This independent verification ensures that the batch meets the claimed specifications before shipment. Below is the certification checklist that buyers should request from every potential supplier:
In the cosmetic formulation industry, C-Peptide is increasingly incorporated into anti-aging serums, eye creams, and moisturizers due to its role in supporting collagen synthesis and skin barrier function. The c-peptide test is used by formulation chemists to confirm that the raw material is free from endotoxins and heavy metals, which could cause irritation or sensitization in topical products. A typical application involves dissolving the peptide in a water phase at 0.1-1.0% concentration, with pH adjusted to 5.5-6.5 for optimal stability.
For laboratory research, C-Peptide is a standard reagent in diabetes-related studies, where it is used to differentiate endogenous insulin production from exogenous insulin administration. Research labs require the highest purity grade, with the c-peptide test confirming that the material is suitable for cell-based assays and ELISA standard curves. Bulk wholesale buyers, such as peptide distributors and contract manufacturing organizations (CMOs), rely on the c-peptide test to validate large-scale lots before repackaging or further processing. In these scenarios, the test ensures that the peptide retains its biological activity and structural integrity throughout the supply chain.
| Item | Our Product (High-Purity C-Peptide) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| HPLC Purity | ≥98.0% | 85-92% | Reduces side reactions in formulations |
| Molecular Weight Confirmation | ±0.5 Da by MS | ±2.0 Da or not reported | Ensures correct peptide identity |
| Endotoxin Level | <0.1 EU/mg | >5.0 EU/mg | Safe for sensitive cell assays |
| Residual Solvents | <100 ppm each | >1000 ppm total | Prevents formulation instability |
| Batch Consistency | CV <3% across lots | CV >10% | Reliable scale-up manufacturing |
When sourcing C-Peptide in bulk quantities, buyers must avoid common pitfalls that lead to costly rejections or formulation failures. The most frequent issue is relying on a supplier’s in-house c-peptide test without independent verification. Always request a third-party CoA from an accredited laboratory, and cross-reference the reported purity with the HPLC chromatogram. Another common mistake is overlooking the peptide content percentage; a product with 98% HPLC purity but only 70% net peptide content will underperform in formulations. The selection standards below provide a buyer checklist for evaluating potential suppliers:
The primary advantage of sourcing C-Peptide with a verified c-peptide test is the assurance of high purity that minimizes batch-to-batch variability. This consistency is critical for cosmetic manufacturers who need to maintain product quality across multiple production runs. Stability is another key benefit; peptides that pass rigorous c-peptide testing exhibit longer shelf lives and better resistance to degradation during formulation and storage. Cost performance is achieved through reduced waste—higher purity means less material is needed to achieve the desired concentration in a final product, lowering overall formulation costs. Finally, technical support from suppliers who provide comprehensive c-peptide test data enables buyers to troubleshoot formulation issues quickly and confidently.
Q1: What is the difference between a c-peptide test and a standard HPLC purity test?
A c-peptide test is a comprehensive analytical protocol that includes HPLC purity determination, molecular weight confirmation by mass spectrometry, and quantification of peptide content. A standard HPLC purity test only measures the main peak area percentage, which can be misleading if the peptide has high purity but low net content or incorrect molecular weight.
Q2: How often should a c-peptide test be performed on bulk peptide lots?
For manufacturing sourcing, a c-peptide test should be performed on every production lot to ensure batch-to-batch consistency. Additionally, a full re-test is recommended after 12 months of storage, even under optimal conditions, to verify that no degradation has occurred.
Q3: Can a c-peptide test detect peptide aggregation or degradation products?
Yes, a comprehensive c-peptide test using reversed-phase HPLC can separate and quantify aggregated species, oxidation products, and deamidation variants. Mass spectrometry further confirms the identity of any degradation peaks, providing a complete picture of the peptide’s quality.